What Adjuvant Screening and Comparison Covers
Adjuvant selection shapes how strongly a cancer vaccine formulation activates innate and adaptive immunity, and candidate adjuvants are rarely interchangeable. This service screens and compares candidate adjuvants for cancer vaccine formulations: each adjuvant is combined with a model antigen or a client-supplied vaccine and tested in parallel immunization or immune-cell assays, then benchmarked against control adjuvants. Readouts typically include innate activation, cytokine responses, antibody titers, and T-cell responses. Deliverables are ranked comparison data and a summary report suitable for adjuvant selection. Scope, group numbers, and readout depth are defined per project during study design.
Parallel dendritic cell maturation and antigen presentation assays can characterize antigen-presenting cell activation during adjuvant comparisons.
What the Screening Program Can Include
Parallel adjuvant comparison
Candidate adjuvants are run side by side under matched conditions, with benchmark comparator groups included so rankings are read against a reference rather than in isolation.
Mouse immunization and immune-cell assays
Adjuvant–antigen combinations are evaluated in mouse immunization models and in immune-cell assays, with the model and assay mix selected during study design.
Dose-response and replicate group design
Dose levels, group sizes, and replicate structure are set per project so that candidate adjuvants can be compared on a consistent basis.
Cytokine, antibody, and T-cell readouts
Readouts typically cover innate activation and cytokine profiling, antibody titers, and T-cell responses; the final readout panel is agreed in the study plan.
How an Adjuvant Screening Engagement Runs
Deliverables: What You Receive
| Deliverable | Description |
|---|---|
| Ranked adjuvant comparison table | Side-by-side readout summary ranking candidate adjuvants against benchmark comparator groups, with group-level values for each assay performed. |
| Cytokine and innate activation dataset | Quantified cytokine profiling and innate immune activation readouts from immune-cell assays, organized by adjuvant, dose, and replicate group. |
| Antibody titer and T-cell response data | Antigen-specific antibody titers and T-cell response measurements from parallel immunization runs, reported per group with control comparisons. |
| Assay control documentation | Records of positive and negative assay controls and benchmark adjuvant groups, so results can be interpreted against defined reference performance. |
| Summary comparison report | A written report summarizing study design, assay methods, observed readouts, and ranked comparison data intended to support adjuvant selection decisions. |
Why Choose Our Adjuvant Screening Service
Parallel comparison, not single-candidate testing
Candidate adjuvants are run in parallel with benchmark comparator groups under a shared study design, so ranking reflects relative performance within the same run rather than across separate studies.
Multiple immune readouts in one program
Each program can combine innate activation, cytokine profiling, antibody titers, and T-cell response measurements, giving a broader comparison basis than any single readout alone.
Flexible fit to your vaccine format
Adjuvants can be tested with a model antigen or with your own vaccine formulation, and dose-response and replicate group design are scoped per project after consultation.
Further Reading
Research reference
1. Sequential STING and CD40 agonism drives massive expansion of tumor-specific T cells in liposomal peptide vaccines
Cellular & Molecular Immunology. 2025. DOI: 10.1038/s41423-024-01249-4.
View articleReady to Compare Your Adjuvant Candidates?
Share your candidate adjuvants, model antigen or vaccine construct, and preferred readouts. We will outline a parallel comparison design with benchmark controls and return a scoped project plan for your review.
Downstream antigen-specific T cell response assays can compare antigen-responsive activity across selected adjuvant conditions.